Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2-N3 status patients: a SEER database analysis
- PMID: 37103742
- DOI: 10.1007/s12282-023-01459-0
Options of locoregional therapy for primary foci of breast cancer influence the rate of nonregional lymph node metastasis in N2-N3 status patients: a SEER database analysis
Abstract
Objective: We aim to use the SEER database to discuss the effect of various surgical methods of primary foci and other influencing factors on the nonregional lymph node (NRLN) metastasis in invasive ductal carcinoma (IDC) patients.
Methods: Clinical information of IDC patients used in this study was obtained from the SEER database. The statistical analyses used included a multivariate logistic regression model, the chi-squared test, log-rank test and propensity score matching (PSM).
Results: 243,533 patients were included in the analysis. 94.3% of NRLN patients had a high N positivity (N3) but an equal distribution in T status. The proportion of operation type, especially BCM and MRM, differed significantly between the N0-N1 and N2-N3 groups in the NRLN metastasis group and nonmetastasis group. Age > 80 years, positive PR, modified radical mastectomy (MRM)/radical mastectomy (RM) and radiotherapy for primary tumor were shown to be protective factors for NRLN metastasis, and higher N positivity was the most significant risk factors. N2-N3 patients receiving MRM had a lower metastasis to NRLN than those receiving BCM (1.4% vs 3.7%, P < 0.001), while this relevance was not discovered in N0-N1 patients. In N2-N3 patients, a better OS was observed in MRM group than BCM group (P < 0.001).
Conclusion: MRM exerted a protective effect on NRLN metastasis compared to BCM in N2-N3 patients but not N0-N1 patients. This implies the need for more consideration when choosing the operation methods of primary foci in patients with high N positivity.
Keywords: Breast cancer; Lymph nodes; Mastectomy; Neoplasm metastasis.
© 2023. The Author(s), under exclusive licence to The Japanese Breast Cancer Society.
Similar articles
-
Surgery on Metastatic Foci is a Better Strategy for Stage IV Breast Cancer Patients with only Nonregional Lymph Node Metastasis.Adv Ther. 2023 Jul;40(7):3247-3262. doi: 10.1007/s12325-023-02557-3. Epub 2023 Jun 3. Adv Ther. 2023. PMID: 37270436
-
Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.Cancer Med. 2023 Apr;12(7):8184-8198. doi: 10.1002/cam4.5620. Epub 2023 Jan 16. Cancer Med. 2023. PMID: 36645113 Free PMC article.
-
Comparison of lymphangiogenesis, lymphatic invasion, and axillary lymph node metastasis in breast carcinoma.Indian J Pathol Microbiol. 2018 Apr-Jun;61(2):176-180. doi: 10.4103/IJPM.IJPM_774_16. Indian J Pathol Microbiol. 2018. PMID: 29676352
-
The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming 8th Edition of the TNM Classification for Lung Cancer.J Thorac Oncol. 2015 Dec;10(12):1675-84. doi: 10.1097/JTO.0000000000000678. J Thorac Oncol. 2015. PMID: 26709477 Review.
-
Ratio and log odds of positive lymph nodes in breast cancer patients with mastectomy.Surg Oncol. 2015 Sep;24(3):239-47. doi: 10.1016/j.suronc.2015.05.001. Epub 2015 May 19. Surg Oncol. 2015. PMID: 26055316 Review.
Cited by
-
Breast-conserving surgery versus modified radical mastectomy in T1-2N3M0 stage breast cancer: a propensity score matching analysis.Breast Cancer. 2024 Sep;31(5):979-987. doi: 10.1007/s12282-024-01611-4. Epub 2024 Jul 8. Breast Cancer. 2024. PMID: 38976120
References
-
- Nash AL, Thomas SM, Plichta JK, Fayanju OM, Hwang ES, Greenup RA, et al. Contralateral axillary nodal metastases: stage IV disease or a manifestation of progressive locally advanced breast cancer? Ann Surg Oncol. 2021;28:5544–52. https://doi.org/10.1245/s10434-021-10461-9 . - DOI - PubMed - PMC
-
- Zhang Z, Zhang Y, Sun X. Therapeutic options for contralateral axillary lymph node metastasis in breast cancer. Curr Probl Cancer. 2021;45:100706. https://doi.org/10.1016/j.currproblcancer.2020.100706 . - DOI - PubMed
-
- Magnoni F, Colleoni M, Mattar D, Corso G, Bagnardi V, Frassoni S, et al. Contralateral axillary lymph node metastases from breast carcinoma: is it time to review TNM cancer staging? Ann Surg Oncol. 2020;27:4488–99. https://doi.org/10.1245/s10434-020-08605-4 . - DOI - PubMed
-
- Daskalova I, Popovska S, Betova T, Velkova A, Ivanova N, Baitchev G, et al. Distant metastasis after radical treatment of breast cancer: risk factors and their prognostic relevance in 378 consecutive patients. J Buon. 2009;14:229–33. - PubMed
-
- Lapcik P, Pospisilova A, Janacova L, Grell P, Fabian P, Bouchal P. How different are the molecular mechanisms of nodal and distant metastasis in luminal a breast cancer? Cancers (Basel). 2020. https://doi.org/10.3390/cancers12092638 . - DOI - PubMed - PMC
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous